
News|Articles|November 18, 2025
ADA Assays for Complex Molecule Development
Author(s)Prolytix
Key Takeaways
Having a robust immunogenicity assay for accurate evaluation of ADA in animal models is important for enabling effective decision-making during development. Learn how a robust anti-drug antibody assay was developed and was capable of detection at the requisite sensitivity and enabled meaningful interpretation of PK data obtained from the preclinical animal model.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
2
PharmTech Weekly News Roundup – Week of December 1, 2025
3
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
4
Raman Spectroscopy—A Game-Changer in the Fight Against Counterfeit Drugs
5
